| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/14/2004 | EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/14/2004 | EP1406630A1 Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406571A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 04/14/2004 | EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 04/14/2004 | EP1301522A4 Novel compounds and methods |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
| 04/14/2004 | EP1189583A4 Indole derivatives |
| 04/14/2004 | EP1156054B1 Drugs containing phosphoric acid derivatives as the active ingredient |
| 04/14/2004 | EP1140072B1 Compounds and methods |
| 04/14/2004 | EP1115708B1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 04/14/2004 | EP1073641B1 New substituted amides, their production and their use |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | EP0839041B1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489460A Remedies/preventives for in flammatory diseases |
| 04/14/2004 | CN1488400A Preparation for preventing and curing endometritis for dairy cattle and preparing method thereof |
| 04/14/2004 | CN1488391A Medicine for treating waist and lower extremities pain |
| 04/14/2004 | CN1488376A Medicinal cap sule for treating enteric disease and nusosinusitis and preparing method thereof |
| 04/14/2004 | CN1488374A Medicinal liquor for traumatic injuries |
| 04/14/2004 | CN1488369A Chinese medicine powder for treating gynaopathy |
| 04/14/2004 | CN1488352A Medicinal composition for antipyretic analgesic for pediatrics |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 04/14/2004 | CN1145606C 2-aminotetrahydronaphthalene, process for their preparation, and pharmaceutical composition for prevention and therapeutic treatment of in flammatory and lor autoimmune pathologies |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720354 Prevention of neutrophil recruitment |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720304 Conjugate comprising a folic acid antagonist and a carrier |
| 04/13/2004 | US6720009 Matrix protein compositions for treating infection |
| 04/13/2004 | US6719996 Galenic composition for low bioavailability medicaments |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/13/2004 | US6719972 Induce antigen specific apoptosis in activated t cells; ligands with monoclonal anti-ctla4 antibody that binds to an epitope of ctla4 |
| 04/13/2004 | CA2185983C Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 04/08/2004 | WO2004029055A1 Fused azole-pyrimidine derivatives |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004029031A2 Therapeutic piperazine compounds |
| 04/08/2004 | WO2004029027A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | WO2004029026A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | WO2004028526A1 Therapeutic agent for rheumatism containing benzamide derivative as active ingredient |
| 04/08/2004 | WO2004028522A1 Analgesic compositions comprising nmda receptor antagonists and benzalkonium chloride |
| 04/08/2004 | WO2004013153A3 Macrolide compounds endowed with antiinflammatory activity |
| 04/08/2004 | WO2004012722A3 Bicifadine formulation |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004003016A3 Marked peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004003015A3 Peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003074060A3 Dna demethylase antisense and chemotherapy combination |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2002100373B1 Skin preparation |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2002076173A3 Inhibitors of glycosaminoglycans |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040068007 Diclofenac salt of lidocaine |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067977 Tropane derivatives useful in therapy |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067964 Antiinflammatory agents |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |